| | 6377-18-0 Basic information More.. |
| Product Name: | CHARTREUSIN | | Synonyms: | CHARTREUSIN;antibioticx-465a;nsc5159;u-7257;chartreusin from streptomyces*chartreusis;LAMBDAMYCIN;10-[[6-Deoxy-2-O-(6-deoxy-3-O-methyl-α-D-galactopyranosyl)-β-D-galactopyranosyl]oxy]-6-hydroxy-1-methylbenzo[h][1]benzopyrano[5,4,3-cde][1]benzopyran-5,12-dione;LaMbdaMycin, NSC 5159, 747, 1293, X465A, G 261A | | CAS: | 6377-18-0 | | MF: | C32H32O14 | | MW: | 640.59 | | EINECS: | | | Mol File: | 6377-18-0.mol |  |
Use
Chartreusin is an antitumor antibiotic that binds to GC-rich tracts in DNA, with a clear preference for B-DNA over Z-DNA. It inhibits RNA synthesis and causes single-strand scission of DNA via the formation of free radicals. Chartreusin is also a potent inhibitor of topoisomerase II.
- Chartreusin
-
- $178.00
- 2026-04-21
- CAS:6377-18-0
- Purity:
- Supply Ability: 10g
|
|
6377-18-0
Recommend Suppliers |
|